| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/25/2005 | WO2005037868A3 Methods of treating nfat-related disorders |
| 08/25/2005 | WO2005037194A3 Collagen interactions with prostate cancer cells |
| 08/25/2005 | WO2005035771A3 Nucleic acid constructs |
| 08/25/2005 | WO2005007827A3 Avian adeno-associated virus vector |
| 08/25/2005 | WO2005007108A3 Asymmetric disulfides and methods of using same |
| 08/25/2005 | WO2004093820A3 Methods and compositions for solid tumor treatment |
| 08/25/2005 | WO2004074450A3 Combination therapy for treating protein deficiencies |
| 08/25/2005 | US20050188429 Method for treating a condition with a cytokine of the GP130 subunit signaling family linked to a polynucleotide encoding SOCS-3 |
| 08/25/2005 | US20050188427 Lysyl oxidase-like 1 (LOXL1) and elastogenesis |
| 08/25/2005 | US20050187178 Compositions comprising alternating 2'-modified nucleosides for use in gene modulation |
| 08/25/2005 | US20050187177 chimeric gene construct composed of a COX-2 promoter operably linked to at least one apoptosis-inducing gene that can cause selectively induced apoptosis in a population of diseased cells; entire classes of cells can be treated with one transfection |
| 08/25/2005 | US20050187176 Method for inhibiting NF-kappa B signaling and use to treat or prevent human diseases |
| 08/25/2005 | US20050187175 Methods and compositions for CPG15-2 |
| 08/25/2005 | US20050187173 A method of delaying the onset of diabetes |
| 08/25/2005 | US20050187154 bone morphogenetic proteins play an important role in adipocyte differentiation; promote brown adipocyte tissue (BAT) differentiation and inhibits white adipose tissue (WAT) adipogenesis |
| 08/25/2005 | US20050187141 Control of gene induced by oxidated lipids in human artery wall cells |
| 08/25/2005 | US20050186668 Hormonally up-regulated, neu-tumor-associated kinase |
| 08/25/2005 | US20050186667 nucleotide sequence encoding PNCK that is temporally expressed during postnatal mammary development in a spatially heterogeneous manner in certain subsets of cells, and overexpressed in a subset of primary breast cancers; used as prognostic tools, screening tools and in therapies |
| 08/25/2005 | US20050186665 Expressed ligand - vascular intercellular signaling molecule |
| 08/25/2005 | US20050186650 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 08/25/2005 | US20050186644 Contacting a sample comprising bladder cells taken from the subject with an antibody that specifically binds to nuclear matrix protein BLCA-4, wherein bladder cancer or risk of developing bladder cancer is indicated if sample contains nuclear matrix protein BLCA-4 |
| 08/25/2005 | US20050186626 Chicken leukemia inhibitory factor (LIF) and gene thereof |
| 08/25/2005 | US20050186604 Using histone acetyltransferase (HAT) inhibitor as therapeutic tool in treatment of cell proliferative disorders |
| 08/25/2005 | US20050186594 Antisense oligonucleotides for controlling G protein-coupled receptor kinase 6 and use in the treatment and prevention of rheumatoid arthritis, drug addiction, hypertension, reproductive and blood disorders |
| 08/25/2005 | US20050186591 Method of treating neurodegenerative disease |
| 08/25/2005 | US20050186589 Interspersed repetitive element RNAs as substrates, inhibitors and delivery vehicles for RNAi |
| 08/25/2005 | US20050186586 Methods and compositions for enhancing the efficacy and specificity of RNAi |
| 08/25/2005 | US20050186582 Compositions and methods of using hexokinase V |
| 08/25/2005 | US20050186575 Corona-virus-like particles comprising functionally deleted genomes |
| 08/25/2005 | US20050186571 Diagnosis and prevention of cancer cell invasion |
| 08/25/2005 | US20050186567 Antisense modulation of peroxisome proliferator-activated receptor gamma expression |
| 08/25/2005 | US20050186562 Method for early detection during the clinical phase of the infection, reliable, rapid, inexpensive, making it possible to adapt the medical care in time |
| 08/25/2005 | US20050186266 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 08/25/2005 | US20050186225 Adenovirus formulations |
| 08/25/2005 | US20050186219 Transgenic plant-based vaccines |
| 08/25/2005 | US20050186212 Trefoil factor 3 (TFF3) as a target for anti-cancer therapy |
| 08/25/2005 | US20050186210 Method for tissue regeneration |
| 08/25/2005 | US20050186209 Protein between 30% but less than 100% identical to a human protein, contains a mutation characteristic of an analogous non-human protein; is capable of raising antibodies in human, antibodies bind to both the human protein and the polypeptide |
| 08/25/2005 | US20050186187 Altering the expression levels of a protein; modulating the activity of secretory leukocyte protease inhibitor (SLPI), CD53, or Transferrin-1 in a cell and culturing the cells |
| 08/25/2005 | US20050186186 Tumor cell having DcR3/TR6, a new member of the TNFR family, anchored at its surface |
| 08/25/2005 | US20050186185 Mammalian cell modified with genes encoding plant late embryogenesis protein HVA1, trehalose transport protein, or a trehalose synthesis pathway; freezing and/or drying organs for storage prior to use |
| 08/25/2005 | US20050186184 Ex vivo or in vitro culturing of mammalian Boundary Cap cells; detection, diagnosis, monitoring of nervous system or neurodegenerative disorders such as demyelination and pain; tissue engineering; drug screening for genes or proteins |
| 08/25/2005 | US20050186181 Selective precipitation of viruses |
| 08/25/2005 | US20050186180 Recombinant virus encoding an antigen of a disease state; second recombinant virus encoding an immunostimulatory molecule with an exogenous immunostimulatory molecule, chemotherapeutic drug, antibiotic, antiviral drug or antifungal drug. |
| 08/25/2005 | US20050186179 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 08/25/2005 | US20050186178 Adenoviral nucleic acid backbone, a heterologous coding sequence encoding granulocyte-macrophage colony stimulating factor |
| 08/25/2005 | DE19833476B4 Genetisch modifizierte CD34-Negative, adhärent wachsende hämatopoetische Stammzellen und deren Verwendung in der Gentherapie Genetically modified CD34-negative adherently growing haematopoietic stem cells and their use in gene therapy |
| 08/25/2005 | CA2556111A1 Method for detecting the risk of cancer, coronary heart disease, and stroke by analysing a catalase gene |
| 08/25/2005 | CA2555848A1 Antibody targeting osteoclast-associated protein |
| 08/25/2005 | CA2555335A1 Rnai therapeutics for treatment of eye neovascularization diseases |
| 08/25/2005 | CA2555145A1 Diagnosis and therapeutics for cancer |
| 08/25/2005 | CA2555142A1 Cell proliferation associated with ccx ckr expression |
| 08/25/2005 | CA2555021A1 Medium for preparing feeder cells for embryonic stem cells and feeder cells |
| 08/25/2005 | CA2554380A1 Mecp2e1 gene |
| 08/25/2005 | CA2554370A1 Compositions and methods of use of w-peptides |
| 08/24/2005 | EP1566445A2 Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 08/24/2005 | EP1566387A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 08/24/2005 | EP1565714A2 Uncaging devices |
| 08/24/2005 | EP1565583A2 Hiv vaccine formulations |
| 08/24/2005 | EP1565582A2 Methods for identifying risk of breast cancer and treatments thereof |
| 08/24/2005 | EP1565581A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 08/24/2005 | EP1565579A2 Methods for identifying risk of breast cancer and treatments thereof |
| 08/24/2005 | EP1565578A2 Rnai-based sensors, caged interfering rnas, and methods of use thereof |
| 08/24/2005 | EP1565487A2 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 08/24/2005 | EP1565218A2 Molecules preferentially associated with effector t cells and methods of their use |
| 08/24/2005 | EP1565212A1 Gastrin compositions and formulations, and methods of use and preparation |
| 08/24/2005 | EP1565210A2 Treatment of mammalian reaction to ige interactions |
| 08/24/2005 | EP1565208A1 The use of cytochrome p450 enzyme cyp2wi as a drug traget for cancer therapy |
| 08/24/2005 | EP1565199A2 Therapeutic polypeptides,nucleic acids encoding same, and methods of use |
| 08/24/2005 | EP0792370B1 Interleukin-1 beta converting enzyme like apoptosis protease-3 and 4 |
| 08/24/2005 | EP0684955B1 Nuclear matrix proteins |
| 08/24/2005 | EP0681483B1 Compositions and methods for delivery of genetic material |
| 08/24/2005 | CN1659288A Method to inhibit cell growth using oligonucleotides |
| 08/24/2005 | CN1659284A Improved chimeric glycoproteins and pseudotyped lentiviral vectors |
| 08/24/2005 | CN1659281A Antiviral therapy on the basis of RNA interference |
| 08/24/2005 | CN1658924A Method of treating biological materials with translating electrical fields and electrode polarity reversal |
| 08/24/2005 | CN1658895A Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis |
| 08/24/2005 | CN1657633A Recombined adenovirus carrying wide-type PTEN gene and its preparation method and use |
| 08/24/2005 | CN1657632A Combination adeno-associated virus of expression human CYP2J2 antigene and its preparation method |
| 08/24/2005 | CN1657631A Recombination adeno-associated virus of expression human antisense phospho lamban gene and its preparation method |
| 08/24/2005 | CN1657617A Clone, expression and anti-tick immanoprotection action of falcate rhipicephalus RhcA and RhcB genes |
| 08/24/2005 | CN1657537A Central body located gene and its use in medicinal region |
| 08/24/2005 | CN1657103A Virus envelope vector for gene transfer |
| 08/24/2005 | CN1657102A SARS-Cov gene vaccine based on epi-position and its contruction |
| 08/24/2005 | CN1657101A Application of liver cells growth factor gene modified myeloid interstitial dry cell in treating mgocardial ischemia |
| 08/24/2005 | CN1215878C Composite hepatitis B vaccine for treatment and its preparation method |
| 08/23/2005 | US6933373 Tumor suppressor protein for as a antiproliferative agent |
| 08/23/2005 | US6933286 Therapeutic delivery compositions and methods of use thereof |
| 08/23/2005 | US6933150 Genetic transduction of cells with nucleic acid codes for transmembrane efflux pumps, gene expression and culturing, for use in bone marrow grafting and gene therapy |
| 08/23/2005 | US6933145 Materials and methods for delivery and expression of heterologous DNA in vertebrate cells |
| 08/23/2005 | US6933142 Mammalian glycosylsulfotransferases expressed in high endothelial cells (HEC-GLCNAC6ST) and polypeptides coded by nucleic acids, used for medical diagnosis, drug screening and therapy |
| 08/23/2005 | US6933133 Treatment of diabetes with synthetic beta cells |
| 08/23/2005 | US6933113 Modulation of endogenous gene expression in cells |
| 08/23/2005 | US6932777 Prophylactic and therapeutic treatment of the ductal epithelium of a mammary gland for cancer |
| 08/23/2005 | CA2295040C Method for coating stents with dna and expression of recombinant genes from dna coated stent in vivo |
| 08/23/2005 | CA2193122C Tetracycline-regulated transcriptional modulators |
| 08/18/2005 | WO2005075672A1 Diagnostics and therapeutics for diseases associated with human cholecystokinin receptor b (cckbr) |
| 08/18/2005 | WO2005074995A2 Combined use of prame inhibitors and hdac inhibitors |
| 08/18/2005 | WO2005074988A1 Nerve cell differentiation inducer |
| 08/18/2005 | WO2005074607A2 Method of treating hemolytic disease |